Efalizumab: ¿un tratamiento seguro para una enfermedad crónica?

Statistics

Is efalizumab: a safe treatment for a chronic disease?

E. Daudéna, MJ. Oñateb

a Servicio de Dermatología. Hospital Universitario la Princesa

b Servicio de Dermatología. Centro de Especialidades de Fuencarral. Hospital Universitario La Paz. Madrid. España.

Read

23000

Times
was read the article

10232

Total PDF

12768

Total HTML

Share statistics

Article information

ISSN: 00017310
Original language: Spanish

DOI:10.1016/S0210-5705(09)71003-9

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 July	51	21	72
2024 June	79	44	123
2024 May	74	35	109
2024 April	77	40	117
2024 March	44	23	67
2024 February	74	44	118
2024 January	73	32	105
2023 December	72	24	96
2023 November	102	35	137
2023 October	49	29	78
2023 September	79	28	107
2023 August	76	28	104
2023 July	86	48	134
2023 June	62	45	107
2023 May	47	45	92
2023 April	66	66	132
2023 March	71	43	114
2023 February	58	37	95
2023 January	48	38	86
2022 December	45	44	89
2022 November	66	51	117
2022 October	60	42	102
2022 September	48	92	140
2022 August	48	41	89
2022 July	54	42	96
2022 June	46	34	80
2022 May	66	48	114
2022 April	45	47	92
2022 March	51	60	111
2022 February	56	44	100
2022 January	79	79	158
2021 December	74	72	146
2021 November	53	40	93
2021 October	66	60	126
2021 September	57	48	105
2021 August	52	30	82
2021 July	44	37	81
2021 June	27	32	59
2021 May	46	44	90
2021 April	106	46	152
2021 March	57	36	93
2021 February	66	27	93
2021 January	48	31	79
2020 December	36	21	57
2020 November	30	22	52
2020 October	34	16	50
2020 September	41	12	53
2020 August	45	15	60
2020 July	28	20	48
2020 June	31	11	42
2020 May	39	13	52
2020 April	35	16	51
2020 March	55	15	70
2020 February	5	2	7
2020 January	0	2	2
2019 September	0	2	2
2019 July	0	4	4
2019 June	0	13	13
2019 May	0	38	38
2019 April	0	16	16
2019 March	0	2	2
2019 February	0	4	4
2018 December	0	2	2
2018 October	0	4	4
2018 September	1	1	2
2018 August	0	6	6
2018 July	0	2	2
2018 June	0	5	5
2018 May	0	7	7
2018 April	0	1	1
2018 March	1	1	2
2018 February	18	13	31
2018 January	20	6	26
2017 December	20	7	27
2017 November	23	15	38
2017 October	13	5	18
2017 September	11	15	26
2017 August	12	31	43
2017 July	9	28	37
2017 June	23	29	52
2017 May	19	8	27
2017 April	17	14	31
2017 March	14	22	36
2017 February	16	13	29
2017 January	16	8	24
2016 December	27	3	30
2016 November	45	7	52
2016 October	36	6	42
2016 September	32	5	37
2016 August	29	10	39
2016 July	19	5	24
2016 June	11	9	20
2016 May	10	13	23
2016 April	20	8	28
2016 March	18	9	27
2016 February	8	9	17
2016 January	20	27	47
2015 December	4	15	19
2015 November	13	16	29
2015 October	7	17	24
2015 September	49	4	53
2015 August	57	4	61
2015 July	258	3	261
2015 June	238	284	522
2015 May	324	396	720
2015 April	332	373	705
2015 March	238	304	542
2015 February	246	339	585
2015 January	215	217	432
2014 December	284	214	498
2014 November	286	247	533
2014 October	345	378	723
2014 September	369	357	726
2014 August	327	338	665
2014 July	409	431	840
2014 June	444	304	748
2014 May	458	348	806
2014 April	332	324	656
2014 March	327	237	564
2014 February	220	174	394
2014 January	318	247	565
2013 December	344	212	556
2013 November	192	177	369
2013 October	329	248	577
2013 September	187	218	405
2013 August	211	251	462
2013 July	252	247	499
2013 June	219	195	414
2013 May	94	143	237
2013 April	99	78	177
2013 March	132	49	181
2013 February	154	83	237
2013 January	112	99	211
2012 December	98	63	161
2012 November	84	60	144
2012 October	83	69	152
2012 September	56	33	89
2012 August	10	6	16
2012 July	1	0	1
2011 March	1	0	1
2011 February	6	0	6
2011 January	6	0	6
2010 December	3	0	3
2010 November	46	0	46
2010 October	49	0	49
2010 September	44	0	44
2010 August	45	0	45
2010 July	8	0	8
2010 June	17	0	17
2010 May	22	0	22
2010 April	18	0	18
2010 February	2	0	2
2009 November	2	0	2
2009 September	10	0	10
2009 August	5	0	5
2009 July	10	0	10
2009 June	12	0	12
2009 May	3	0	3
2009 April	7	0	7
2009 March	9	0	9
2008 September	5	0	5
2008 August	17	0	17
2008 July	34	0	34
2008 June	40	0	40
2008 May	54	0	54
2008 April	1	0	1

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter